Now showing items 1-20 of 4677

      "Borderline" fluorotic region in Serbia: correlations among fluoride in drinking water, biomarkers of exposure and dental fluorosis in schoolchildren [1]
      "In silico" metode u toksikologiji za procenu bezbednosti lekova [1]
      (-)-Epicatechin-induced relaxation of isolated human saphenous vein: Roles of K+ and Ca2+ channels [1]
      -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis [1]
      12-Tungstophosphoric acid/BEA zeolite composites - Characterization and application for pesticide removal [1]
      17 beta-carboxamide steroids - in vitro prediction of human skin permeability and retention using PAMPA technique [1]
      17 beta-Estradiol influences in vitro response of aged rat splenic conventional dendritic cells to TLR4 and TLR7/8 agonists in an agonist specific manner [1]
      2-[2-(Trifluoromethyl)phenyl]-2H-1-benzopyran-4(3H)-one [1]
      25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? [1]
      3,5-Dinitrosalicylic acid-assisted synthesis of self-assembled polyaniline nanorods [1]
      3,5-nonadiyne isolated from the rhizome of Cachrys ferulacea inhibits endogenous nitric oxide release by rat peritoneal macrophages [1]
      3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists [1]
      3D-QSAR modelovanje i analiza farmakofore antagonista serotoninskih 5-HT2A receptora [1]
      3D-QSAR studies and pharmacophore identification of AT(1) receptor antagonists [1]
      3D-QSAR studija i razvoj farmakofore agonista serotoninskih 5-HT2A receptora [1]
      3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists [1]
      3D-QSAR study of adenosine 5'-phosphosulfate (APS) analouges as ligands for APS reductase [1]
      3D-QSAR студија аналога аденозин 5'-фосфосулфата (APS) као лиганда за APS редуктазу [1]
      3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity [1]
      4-Hydroxynonenal in Parkinson's disease [1]